ESPR

Esperion Therapeutics, Inc. Press Releases

$15.02
*  
0.06
0.4%
Get ESPR Alerts
*Delayed - data as of May 23, 2016  -  Find a broker to begin trading ESPR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ESPR Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing





Glancy Prongay & Murray LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit against Esperion Therapeutics, Inc.
3/8/2016 10:30:00 AM - Business Wire
▼-13.53 % Price Change since this news event. The Volume Ratio is 0.88.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




The Former Attorney General of Louisiana & Kahn Swick & Foti, LLC Remind Large Investors of Lead Plaintiff Deadline in Class Action Lawsuit Against Esperion Therapeutics, Inc. - ESPR
2/26/2016 10:03:00 PM - PR Newswire
▼-3.35 % Price Change since this news event. The Volume Ratio is 1.26.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day